The Lancet warns of drugs risk.
In an editorial, The Lancet said the risks of easily available access to statin drugs were unknown, and there was no evidence that the move will save lives.
It suggested that the real reason for introducing over-thecounter statins was to save money, with the drugs expected to cost the NHS more than pounds 2 billion a year by 2010.
From July, the statin drug simvastatin will be available without prescription in the UK. The drug will be sold at chemist shops to people at moderate risk of heart disease. When the change takes place, Britain will be the first country in the world to permit overthe-counter (OTC) sales of statins.
The Lancet pointed out that there had been no trials of OTC statins for primary prevention of heart disease.
|Printer friendly Cite/link Email Feedback|
|Publication:||The Birmingham Post (England)|
|Date:||May 21, 2004|
|Previous Article:||Leicester players welcome verdict.|
|Next Article:||CIA raid 'America's friend' Chalabi.|
|New breast cancer hope.|
|Cancer mum in drug win.|
|Major International AIDS Society Conference in Sydney, Australia, July 22-25.|
|Nursing moms warned of codeine risk to infants.|